SAN FRANCISCO, May 29, 2025 /PRNewswire/ — Darmiyan, Inc., a leading brain health technology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s post-market surveillance study for BrainSee, its groundbreaking clinical prognostic tool for Alzheimer’s disease. This 7-year study aims to further validate the safety and effectiveness of BrainSee in a socio-demographically diverse patient population across the United States. The insights gained will also support pharmaceutical companies and contract research organizations (CROs) in identifying optimal candidates for next-generation Alzheimer’s clinical trials—advancing both precision and equity in patient selection.

CENTER VALLEY, Pa., May 29, 2025 /PRNewswire/ — Olympus Corp., a global medical technology company committed to making people’s lives healthier, safer and more fulfilling, announced today the launch of the ScopeLocker Air endoscope drying cabinet, offering a new drying option for healthcare facilities.

Georgia Tech researchers have just shared a game-changing breakthrough: a nearly invisible brain-computer interface (BCI) that fits between hair follicles and sits just beneath the skin. No bulky headgear, no conductive gel – just a wireless sensor smaller than a millimeter, picking up brain signals with 96.4% accuracy, even while walking or running.